EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment

Kimia Zandieh, Lena Cook, Kai Zhao, Constanze Nagl, Yutong Gao, Pietro diFazio, Detlef K Bartsch, Uta-Maria Bauer, Marion Meixner, Daniela Yildiz, Corinna Keber, Christopher Nimsky und 1 weitere

Cellular Oncology · 03.08.2026 · 49 (4)

DOI: 10.1007/s13402-026-01266-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 03.08.2026. Verfasst von Kimia Zandieh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Philipps University Marburg, Baldingerstrasse, 35033, Marburg, Germany. Hauptthemen laut MEDLINE: Tumor Microenvironment, ADAM Proteins, Membrane Proteins, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Philipps-Universität Marburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with limited therapeutic options, driven in part by its immunosuppressive tumor microenvironment (TME). Tumor-associated macrophages (TAMs) and neutrophils (TANs) contribute to tumor progression and immune evasion. A Disintegrin and Metalloproteinase 8 (ADAM8), a zinc-dependent protease, is strongly upregulated in PDAC and correlates with poor clinical outcomes, suggesting a regulatory role in tumor progression.

Methods

Wild-type (WT) and Adam8 knockout (A8KO) PDAC cell lines were generated using the CRISPR-Cas9 technique, and PDAC mouse models with or without Adam8 expression were established to investigate the role of ADAM8 in tumor and immune cells. In vitro assays, including Western blotting, qPCR, migration and invasion assays, proliferation assays, ELISA, cytokine and proteome analyses, as well as co-culture experiments with PDAC cells and either macrophages or neutrophils, were employed to assess the effects of ADAM8 on tumor–immune cell crosstalk. In parallel, in vivo WT and A8KO KPC models were generated, genotyped, and monitored to evaluate the impact of ADAM8 on survival, tumor growth, and immune cell recruitment within the PDAC TME.

Results

ADAM8 deletion reduced tumor cell proliferation and migration, associated with reduced activation of FAK/Src/STAT3 signaling and altered secretion of cytokines including GM-CSF, M-CSF, ICAM-1, and TNF-α. Co-culture assays demonstrated that ADAM8 enhanced reciprocal signaling between tumor cells and TAMs/TANs, promoting pro-oncogenic activation. Migration assays and in vivo analyses revealed that ADAM8 facilitated recruitment of macrophages and neutrophils in PDAC TME, while Adam8 KO tumors exhibited reduced immune infiltration and altered macrophage polarization.

Conclusion

Our findings demonstrate that ADAM8 promotes PDAC aggressiveness by enhancing tumor cell proliferation and migration, activating FAK/Src/STAT3 signaling, and driving macrophage and neutrophil recruitment through cytokine regulation. By orchestrating both tumor-intrinsic pathways and tumor–immune interactions, ADAM8 emerges as a key determinant of PDAC progression and a systemic target for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentADAM ProteinsMembrane ProteinsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsAnimalsHumansCell Line, TumorCell MovementCell ProliferationSignal TransductionNeutrophilsMice, KnockoutSTAT3 Transcription FactorMiceMacrophagessrc-Family KinasesFocal Adhesion Kinase 1Antigens, CD

Stichwörter der Autor:innen

ADAM8FAKMacrophageNeutrophilPDACSTAT3SrcTumor microenvironment

Substanzen

ADAM ProteinsMembrane ProteinsADAM8 protein, humanSTAT3 Transcription FactorAdam8 protein, mousesrc-Family KinasesFocal Adhesion Kinase 1Antigens, CD

Autor:innen und Institutionen

  • Department of Neurosurgery, Philipps University Marburg, Baldingerstrasse, 35033, Marburg, Germany.
  • Visceral Surgery, Philipps University Marburg, Baldingerstrasse, 35033, Marburg, Germany.
  • Institute for Molecular Biology and Tumor Research, Philipps University Marburg, Hans-Meerwein-Strasse 2, 35043, Marburg, Germany.
  • Institute for Pharmacology, Homburg University, Homburg, Germany.
  • Institute of Pathology, Philipps University Marburg, Baldingerstrasse, 35033, Marburg, Germany.
  • Department of Neurosurgery, Philipps University Marburg, Baldingerstrasse, 35033, Marburg, Germany. jbartsch@med.uni-marburg.de.

ORCID-Profile: Jörg W Bartsch

Förderung

  • Philipps-Universität Marburg

Zitieren

APA

Zandieh, K., Cook, L., Zhao, K., Nagl, C., Gao, Y., diFazio, P., Bartsch, D. K., Bauer, U. M., Meixner, M., Yildiz, D., Keber, C., Nimsky, C., & Bartsch, J. W. (2026). Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment. Cellular Oncology, 49(4). https://doi.org/10.1007/s13402-026-01266-7

Vancouver

Zandieh K, Cook L, Zhao K, Nagl C, Gao Y, diFazio P, et al. Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment. Cellular Oncology. 2026;49(4). doi:10.1007/s13402-026-01266-7

BibTeX
@article{Zandieh2026,
  author = {Zandieh, Kimia and Cook, Lena and Zhao, Kai and Nagl, Constanze and Gao, Yutong and diFazio, Pietro and Bartsch, Detlef K and Bauer, Uta-Maria and Meixner, Marion and Yildiz, Daniela and Keber, Corinna and Nimsky, Christopher and Bartsch, Jörg W},
  title = {Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment},
  journal = {Cellular Oncology},
  year = {2026},
  volume = {49},
  number = {4},
  doi = {10.1007/s13402-026-01266-7}
}
Kostenlos starten →